COMMUNIQUÉS West-GlobeNewswire

-
IntelGenx Receives First Shipment of Cannabis Extract from Tilray® for Production of Cannabis-Infused Oral Film
28/05/2019 -
Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer
28/05/2019 -
VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents
28/05/2019 -
Translate Bio to Present at the Jefferies 2019 Healthcare Conference
28/05/2019 -
Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
28/05/2019 -
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia
28/05/2019 -
ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer’s Disease with Selectivity for the Neurotoxic Form of Tau
28/05/2019 -
Akcea Therapeutics to Present at Upcoming Investor Conferences
28/05/2019 -
Kezar Life Sciences Announces Acceptance of Abstract for Presentation of First in Patient Study with KZR-616 at EULAR 2019 Annual Meeting
28/05/2019 -
RedHill Biopharma Appoints Dr. June Almenoff as Chief Scientific Officer
28/05/2019 -
AnaptysBio to Present at the Jefferies 2019 Healthcare Conference
28/05/2019 -
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
28/05/2019 -
BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
28/05/2019 -
HEXO Corp formalizes US presence by naming Michael Monahan as Chief Financial Officer and establishing HEXO USA Inc. in Delaware
28/05/2019 -
HEXO Corp officialise sa présence aux États-Unis : nomination de Michael Monahan à titre de directeur des finances et création d’HEXO USA Inc. dans le Delaware
28/05/2019 -
Quotient Limited Recaps Recent Milestone Achievement and Updates on the Initial Serological Disease Screening CE Mark Submission, planned 2019 US Field Trials and Reports Record Financial Results
28/05/2019 -
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference
28/05/2019 -
Transactions in relation to share buyback program
28/05/2019 -
Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022
28/05/2019
Pages